EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,014 | -53.7% | 10,004 | 0.0% | 0.02% | -47.6% |
| Q2 2023 | $73,529 | -29.1% | 10,004 | 0.0% | 0.04% | -33.3% |
| Q1 2023 | $103,641 | -12.3% | 10,004 | 0.0% | 0.06% | -25.0% |
| Q4 2022 | $118,147 | -43.7% | 10,004 | 0.0% | 0.08% | -52.0% |
| Q3 2022 | $210,000 | -32.5% | 10,004 | 0.0% | 0.18% | -28.6% |
| Q2 2022 | $311,000 | -24.3% | 10,004 | 0.0% | 0.24% | -9.3% |
| Q1 2022 | $411,000 | -5.5% | 10,004 | 0.0% | 0.27% | -2.2% |
| Q4 2021 | $435,000 | -13.2% | 10,004 | 0.0% | 0.28% | -18.8% |
| Q3 2021 | $501,000 | -20.5% | 10,004 | 0.0% | 0.34% | -15.8% |
| Q2 2021 | $630,000 | -32.2% | 10,004 | 0.0% | 0.40% | -29.0% |
| Q1 2021 | $929,000 | -10.2% | 10,004 | 0.0% | 0.57% | -30.2% |
| Q4 2020 | $1,034,000 | 0.0% | 10,004 | 0.0% | 0.82% | +0.7% |
| Q3 2020 | $1,034,000 | – | 10,004 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |